Immix Biopharma Ownership 2024 | Who Owns Immix Biopharma Now?

Overview Forecast RevenueFinancials Chart

Institutional Ownership

7.85%

Insider Ownership

40.18%

Retail Ownership

51.97%

Institutional Holders

9.00

Immix Biopharma Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
AIGH CAPITAL MANAGEMENT LLC	6.00%	0.87%	1,406,680	-148,320	-9.54%	2,785,226	Jun 30, 2024
BLEICHROEDER LP	3.63%	0.50%	850,000	-	-	1,683,000	Jun 30, 2024
CABLE CAR CAPITAL LLC	3.40%	1.66%	796,100	125,642	18.74%	1,576,278	Jun 30, 2024
VANGUARD GROUP INC	2.55%	-	598,537	142,351	31.20%	1,185,103	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	0.66%	0.00%	154,685	-110,815	-41.74%	306,276	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.61%	-	142,128	17,358	13.91%	281,454	Jun 30, 2024
PRIVATE ADVISOR GROUP, LLC	0.28%	0.00%	65,175	-33,600	-34.02%	129,047	Jun 30, 2024
MORGAN STANLEY	0.25%	-	58,457	4,412	8.16%	115,745	Jun 30, 2024
STATE STREET CORP	0.18%	-	42,960	-	-	85,061,000	Jun 30, 2024
NORTHERN TRUST CORP	0.17%	-	38,914	-	-	77,050,000	Jun 30, 2024
TOCQUEVILLE ASSET MANAGEMENT L.P.	0.16%	0.00%	37,800	-	-	74,844	Jun 30, 2024
FNY INVESTMENT ADVISERS, LLC	0.14%	0.04%	32,500	7,000	27.45%	64,000	Jun 30, 2024
INVST, LLC	0.12%	0.01%	27,000	27,000	100.00%	57,240	Jun 30, 2024
MILLENNIUM MANAGEMENT LLC	0.11%	-	26,300	-27,981	-51.55%	52,074	Jun 30, 2024
COMMONWEALTH EQUITY SERVICES, LLC	0.11%	0.00%	26,080	-	-	52,000	Jun 30, 2024
TRITONPOINT WEALTH, LLC	0.10%	0.00%	24,526	-	-	48,561	Jun 30, 2024
SQUAREPOINT OPS LLC	0.10%	0.00%	23,010	23,010	100.00%	45,560	Jun 30, 2024
XTX TOPCO LTD	0.08%	0.00%	17,663	-34,534	-66.16%	34,973	Jun 30, 2024
CORSAIR CAPITAL MANAGEMENT, L.P.	0.06%	0.00%	14,217	-55,168	-79.51%	28,150	Jun 30, 2024
BLACKROCK INC.	0.06%	-	13,455	-5,866	-30.36%	26,641	Jun 30, 2024

Immix Biopharma's largest institutional shareholder is AIGH CAPITAL MANAGEMENT LLC, holding 6.00% of the company's total share outstanding, currently valued at $2.79M. The top 10 institutional shareholders own together 17.72% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CABLE CAR CAPITAL LLC	3.40%	1.66%	796,100	125,642	18.74%	1,576,278	Jun 30, 2024
AIGH CAPITAL MANAGEMENT LLC	6.00%	0.87%	1,406,680	-148,320	-9.54%	2,785,226	Jun 30, 2024
BLEICHROEDER LP	3.63%	0.50%	850,000	-	-	1,683,000	Jun 30, 2024
FNY INVESTMENT ADVISERS, LLC	0.14%	0.04%	32,500	7,000	27.45%	64,000	Jun 30, 2024
INVST, LLC	0.12%	0.01%	27,000	27,000	100.00%	57,240	Jun 30, 2024
TRITONPOINT WEALTH, LLC	0.10%	0.00%	24,526	-	-	48,561	Jun 30, 2024
CORSAIR CAPITAL MANAGEMENT, L.P.	0.06%	0.00%	14,217	-55,168	-79.51%	28,150	Jun 30, 2024
XTX TOPCO LTD	0.08%	0.00%	17,663	-34,534	-66.16%	34,973	Jun 30, 2024
TOCQUEVILLE ASSET MANAGEMENT L.P.	0.16%	0.00%	37,800	-	-	74,844	Jun 30, 2024
PRIVATE ADVISOR GROUP, LLC	0.28%	0.00%	65,175	-33,600	-34.02%	129,047	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	0.66%	0.00%	154,685	-110,815	-41.74%	306,276	Jun 30, 2024
OLD NATIONAL BANCORP /IN/	0.04%	0.00%	10,000	-	-	19,800	Jun 30, 2024
TORTOISE INVESTMENT MANAGEMENT, LLC	0.01%	0.00%	1,300	-	-	2,574	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.02%	0.00%	3,986	-1,710	-30.02%	7,893	Jun 30, 2024
COMMONWEALTH EQUITY SERVICES, LLC	0.11%	0.00%	26,080	-	-	52,000	Jun 30, 2024
COLONY GROUP, LLC	0.05%	0.00%	11,900	11,900	100.00%	24,000	Jun 30, 2024
SQUAREPOINT OPS LLC	0.10%	0.00%	23,010	23,010	100.00%	45,560	Jun 30, 2024
STEWARD PARTNERS INVESTMENT ADVISORY, LLC	0.01%	-	1,492	-	-	2,954	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.61%	-	142,128	17,358	13.91%	281,454	Jun 30, 2024
MILLENNIUM MANAGEMENT LLC	0.11%	-	26,300	-27,981	-51.55%	52,074	Jun 30, 2024

The largest Immix Biopharma shareholder by % of total assets is CABLE CAR CAPITAL LLC. The company owns 796.10K shares of Immix Biopharma (IMMX), representing 1.66% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VANGUARD GROUP INC	2.55%	-	598,537	142,351	31.20%	1,185,103	Jun 30, 2024
CABLE CAR CAPITAL LLC	3.40%	1.66%	796,100	125,642	18.74%	1,576,278	Jun 30, 2024
INVST, LLC	0.12%	0.01%	27,000	27,000	100.00%	57,240	Jun 30, 2024
SQUAREPOINT OPS LLC	0.10%	0.00%	23,010	23,010	100.00%	45,560	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.61%	-	142,128	17,358	13.91%	281,454	Jun 30, 2024
COLONY GROUP, LLC	0.05%	0.00%	11,900	11,900	100.00%	24,000	Jun 30, 2024
FNY INVESTMENT ADVISERS, LLC	0.14%	0.04%	32,500	7,000	27.45%	64,000	Jun 30, 2024
MORGAN STANLEY	0.25%	-	58,457	4,412	8.16%	115,745	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	950	950	100.00%	1,881	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	115	115	100.00%	228	Jun 30, 2024
STATE STREET CORP	0.18%	-	42,960	-	-	85,061,000	Jun 30, 2024
NORTHERN TRUST CORP	0.17%	-	38,914	-	-	77,050,000	Jun 30, 2024
STEWARD PARTNERS INVESTMENT ADVISORY, LLC	0.01%	-	1,492	-	-	2,954	Jun 30, 2024
COMMONWEALTH EQUITY SERVICES, LLC	0.11%	0.00%	26,080	-	-	52,000	Jun 30, 2024
TORTOISE INVESTMENT MANAGEMENT, LLC	0.01%	0.00%	1,300	-	-	2,574	Jun 30, 2024
OLD NATIONAL BANCORP /IN/	0.04%	0.00%	10,000	-	-	19,800	Jun 30, 2024
TOCQUEVILLE ASSET MANAGEMENT L.P.	0.16%	0.00%	37,800	-	-	74,844	Jun 30, 2024
TRITONPOINT WEALTH, LLC	0.10%	0.00%	24,526	-	-	48,561	Jun 30, 2024
BLEICHROEDER LP	3.63%	0.50%	850,000	-	-	1,683,000	Jun 30, 2024
WELLS FARGO & COMPANY/MN	0.00%	-	330	-104	-23.96%	653	Jun 30, 2024

As of Jun 30 2024, Immix Biopharma's largest institutional buyer is VANGUARD GROUP INC. The company purchased 142.35K stocks of IMMX, valued at $1.19M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
AIGH CAPITAL MANAGEMENT LLC	6.00%	0.87%	1,406,680	-148,320	-9.54%	2,785,226	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	0.66%	0.00%	154,685	-110,815	-41.74%	306,276	Jun 30, 2024
CORSAIR CAPITAL MANAGEMENT, L.P.	0.06%	0.00%	14,217	-55,168	-79.51%	28,150	Jun 30, 2024
XTX TOPCO LTD	0.08%	0.00%	17,663	-34,534	-66.16%	34,973	Jun 30, 2024
PRIVATE ADVISOR GROUP, LLC	0.28%	0.00%	65,175	-33,600	-34.02%	129,047	Jun 30, 2024
MILLENNIUM MANAGEMENT LLC	0.11%	-	26,300	-27,981	-51.55%	52,074	Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP	-	-	-	-24,528	-100.00%	-	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	-	-	-	-22,862	-100.00%	-	Jun 30, 2024
WALLEYE CAPITAL LLC	-	-	-	-21,926	-100.00%	-	Jun 30, 2024
JPMORGAN CHASE & CO	-	-	-	-9,039	-100.00%	-	Jun 30, 2024
BLACKROCK INC.	0.06%	-	13,455	-5,866	-30.36%	26,641	Jun 30, 2024
UBS GROUP AG	0.01%	-	3,154	-2,104	-40.02%	6,245	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.02%	0.00%	3,986	-1,710	-30.02%	7,893	Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	-	-	-	-1,243	-100.00%	-	Jun 30, 2024
SIMPLEX TRADING, LLC	-	-	-	-509	-100.00%	-	Jun 30, 2024
WELLS FARGO & COMPANY/MN	0.00%	-	330	-104	-23.96%	653	Jun 30, 2024
BLEICHROEDER LP	3.63%	0.50%	850,000	-	-	1,683,000	Jun 30, 2024
TRITONPOINT WEALTH, LLC	0.10%	0.00%	24,526	-	-	48,561	Jun 30, 2024
TOCQUEVILLE ASSET MANAGEMENT L.P.	0.16%	0.00%	37,800	-	-	74,844	Jun 30, 2024
OLD NATIONAL BANCORP /IN/	0.04%	0.00%	10,000	-	-	19,800	Jun 30, 2024

As of Jun 30 2024, Immix Biopharma's biggest institutional seller is AIGH CAPITAL MANAGEMENT LLC. The company sold -0.15M shares of IMMX, valued at $2.79M.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
INVST, LLC	0.12%	0.01%	27,000	27,000	100.00%	57,240	Jun 30, 2024
SQUAREPOINT OPS LLC	0.10%	0.00%	23,010	23,010	100.00%	45,560	Jun 30, 2024
COLONY GROUP, LLC	0.05%	0.00%	11,900	11,900	100.00%	24,000	Jun 30, 2024

Immix Biopharma's largest new institutional shareholder by number of shares is INVST, LLC, purchased 27.00K shares, valued at $57.24K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
DIMENSIONAL FUND ADVISORS LP	-	-	-	-24,528	-100.00%	-	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	-	-	-	-22,862	-100.00%	-	Jun 30, 2024
WALLEYE CAPITAL LLC	-	-	-	-21,926	-100.00%	-	Jun 30, 2024
JPMORGAN CHASE & CO	-	-	-	-9,039	-100.00%	-	Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	-	-	-	-1,243	-100.00%	-	Jun 30, 2024
SIMPLEX TRADING, LLC	-	-	-	-509	-100.00%	-	Jun 30, 2024

Immix Biopharma's largest sold out institutional shareholder by shares sold is DIMENSIONAL FUND ADVISORS LP, sold -24.53K shares, valued at -, as of undefined.

Immix Biopharma Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
360 Funds	0.14%	30,000	30,000	-	Mar 31, 2024
VANGUARD INDEX FUNDS	0.00%	449,796	181,979	67.95%	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	81,664	3,774	4.85%	Feb 29, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	23,822	11,911	100.00%	Jan 31, 2024
iSHARES TRUST	0.00%	16,137	-424	-2.56%	Mar 31, 2024
EQ ADVISORS TRUST	0.00%	1,151	-	-	Mar 31, 2024

Immix Biopharma's largest mutual fund holder by % of total assets is "360 Funds", owning 30.00K shares, compromising 0.14% of its total assets.

Immix Biopharma Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	9	-73.53%
31 Mar, 24	34	30.77%
31 Dec, 23	26	73.33%
30 Sep, 23	15	-11.76%
30 Jun, 23	17	41.67%
31 Mar, 23	12	-33.33%
31 Dec, 22	18	157.14%
30 Sep, 22	7	16.67%
30 Jun, 22	6	-14.29%
31 Mar, 22	7	-36.36%
31 Dec, 21	11	-

As of 30 Jun 24, 9 institutions are holding Immix Biopharma's shares, representing a decrease of -73.53% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	1,840,040	-63.85%
31 Mar, 24	5,090,000	575.54%
31 Dec, 23	753,468	100.29%
30 Sep, 23	376,196	-40.60%
30 Jun, 23	633,274	58.00%
31 Mar, 23	400,796	-9.07%
31 Dec, 22	440,750	47.43%
30 Sep, 22	298,959	63.02%
30 Jun, 22	183,385	25.19%
31 Mar, 22	146,485	-90.48%
31 Dec, 21	1,538,439	-

Immix Biopharma (IMMX) has 1.84M shares outstanding as of 30 Jun 24, down -63.85% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	7.85%	1.20%
31 Mar, 24	25.55%	155.33%
31 Dec, 23	4.06%	64.81%
30 Sep, 23	2.50%	12.05%
30 Jun, 23	4.56%	54.79%
31 Mar, 23	2.88%	28.63%
31 Dec, 22	3.17%	68.86%
30 Sep, 22	2.15%	123.01%
30 Jun, 22	1.32%	117.76%
31 Mar, 22	1.06%	0.26%
31 Dec, 21	20.31%	-

As of 30 Jun 24, Immix Biopharma is held by 7.85% institutional shareholders, representing a 1.20% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	2	-92.86%
31 Mar, 24	28	47.37%
31 Dec, 23	19	90.00%
30 Sep, 23	10	11.11%
30 Jun, 23	9	28.57%
31 Mar, 23	7	-46.15%
31 Dec, 22	13	116.67%
30 Sep, 22	6	50.00%
30 Jun, 22	4	-33.33%
31 Mar, 22	6	-45.45%
31 Dec, 21	11	-

2 institutional shareholders have increased their position in IMMX stock as of 30 Jun 24 compared to 28 in the previous quarter (a -92.86% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	3	50.00%
31 Mar, 24	2	-
31 Dec, 23	2	-
30 Sep, 23	-	-100.00%
30 Jun, 23	4	300.00%
31 Mar, 23	1	-50.00%
31 Dec, 22	2	-
30 Sep, 22	-	-
30 Jun, 22	-	-100.00%
31 Mar, 22	1	-
31 Dec, 21	-	-

3 institutional shareholders have reduced their position in IMMX stock as of 30 Jun 24 compared to 2 in the previous quarter (a 50.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	9	-73.53%	1,840,040	-63.85%	7.85%	1.20%	2	-92.86%	3	50.00%
31 Mar, 24	34	30.77%	5,090,000	575.54%	25.55%	155.33%	28	47.37%	2	-
31 Dec, 23	26	73.33%	753,468	100.29%	4.06%	64.81%	19	90.00%	2	-
30 Sep, 23	15	-11.76%	376,196	-40.60%	2.50%	12.05%	10	11.11%	-	-100.00%
30 Jun, 23	17	41.67%	633,274	58.00%	4.56%	54.79%	9	28.57%	4	300.00%
31 Mar, 23	12	-33.33%	400,796	-9.07%	2.88%	28.63%	7	-46.15%	1	-50.00%
31 Dec, 22	18	157.14%	440,750	47.43%	3.17%	68.86%	13	116.67%	2	-
30 Sep, 22	7	16.67%	298,959	63.02%	2.15%	123.01%	6	50.00%	-	-
30 Jun, 22	6	-14.29%	183,385	25.19%	1.32%	117.76%	4	-33.33%	-	-100.00%
31 Mar, 22	7	-36.36%	146,485	-90.48%	1.06%	0.26%	6	-45.45%	1	-
31 Dec, 21	11	-	1,538,439	-	20.31%	-	11	-	-	-

Immix Biopharma Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 31, 2024	Hsu Jason	director	-	P-Purchase	Buy	6,000	$2.15	$12.88K	822,200
Jul 31, 2024	Hsu Jason	director	-	P-Purchase	Buy	3,200	$2.07	$6.64K	816,200
Jun 10, 2024	Rachman Ilya M	director, officer	CEO and Chairman	P-Purchase	Buy	2,600	$2.13	$5.54K	1,136,259
Jun 10, 2024	Morris Gabriel S	director, officer	CFO	P-Purchase	Buy	2,500	$2.12	$5.30K	285,834
Jun 05, 2024	Morris Gabriel S	director, officer	CFO	P-Purchase	Buy	3,300	$1.81	$5.97K	283,334
Jun 05, 2024	Rachman Ilya M	director, officer	CEO and Chairman	P-Purchase	Buy	3,300	$1.81	$5.97K	1,133,659

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 31, 2024	Hsu Jason	director	-	P-Purchase	Buy	6,000	$2.15	$12.88K	822,200
Jul 31, 2024	Hsu Jason	director	-	P-Purchase	Buy	3,200	$2.07	$6.64K	816,200
Jun 10, 2024	Rachman Ilya M	director, officer	CEO and Chairman	P-Purchase	Buy	2,600	$2.13	$5.54K	1,136,259
Jun 10, 2024	Morris Gabriel S	director, officer	CFO	P-Purchase	Buy	2,500	$2.12	$5.30K	285,834
Jun 05, 2024	Morris Gabriel S	director, officer	CFO	P-Purchase	Buy	3,300	$1.81	$5.97K	283,334
Jun 05, 2024	Rachman Ilya M	director, officer	CEO and Chairman	P-Purchase	Buy	3,300	$1.81	$5.97K	1,133,659

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 31, 2024	Hsu Jason	director	-	P-Purchase	Buy	6,000	$2.15	$12.88K	822,200
Jul 31, 2024	Hsu Jason	director	-	P-Purchase	Buy	3,200	$2.07	$6.64K	816,200
Jun 21, 2024	Marquet Magda	director	-	A-Award	Buy	33,000	$2.04	$67.32K	33,000
Jun 21, 2024	Chudnovsky Yekaterina	director, 10 percent owner		A-Award	Buy	33,000	$2.04	$67.32K	33,000
Jun 21, 2024	Hsu Jason	director	-	A-Award	Buy	33,000	$2.04	$67.32K	33,000
Jun 21, 2024	Rachman Ilya M	director, officer	CEO and Chairman	A-Award	Buy	340,000	$2.04	$693.60K	340,000
Jun 21, 2024	Ng Carey	director	-	A-Award	Buy	33,000	$2.04	$67.32K	33,000
Jun 21, 2024	BUCHAN JANE	director	-	A-Award	Buy	33,000	$2.04	$67.32K	33,000
Jun 21, 2024	Morris Gabriel S	director, officer	CFO	A-Award	Buy	340,000	$2.04	$693.60K	340,000
Jun 21, 2024	Adams Helen C.	director	-	A-Award	Buy	33,000	$2.04	$67.32K	33,000
Jun 10, 2024	Rachman Ilya M	director, officer	CEO and Chairman	P-Purchase	Buy	2,600	$2.13	$5.54K	1,136,259
Jun 10, 2024	Morris Gabriel S	director, officer	CFO	P-Purchase	Buy	2,500	$2.12	$5.30K	285,834
Jun 05, 2024	Morris Gabriel S	director, officer	CFO	P-Purchase	Buy	3,300	$1.81	$5.97K	283,334
Jun 05, 2024	Rachman Ilya M	director, officer	CEO and Chairman	P-Purchase	Buy	3,300	$1.81	$5.97K	1,133,659
May 20, 2024	Adams Helen C.	director	-	A-Award	Buy	74,241	-	-	174,754
May 20, 2024	Adams Helen C.	director	-	A-Award	Buy	87,740	-	-	100,740
May 20, 2024	Rachman Ilya M	director, officer	CEO and Chairman	A-Award	Buy	218,359	-	-	1,130,359
May 20, 2024	Hsu Jason	director	-	A-Award	Buy	25,512	$2.47	$63.01K	25,512
May 20, 2024	Hsu Jason	director	-	A-Award	Buy	21,587	$2.47	$53.32K	21,587
May 20, 2024	BUCHAN JANE	director	-	A-Award	Buy	24,153	$2.47	$59.66K	24,153

The last insider buy of IMMX was made by Hsu Jason on Jul 31 2024, buying 6,000 shares at $2.15 per share (worth $12.88K).

Immix Biopharma Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	20	-	-
Q4 2023	2	-	-
Q3 2023	22	-	-
Q4 2022	4	-	-
Q3 2022	8	2	400.00%
Q4 2021	11	16	68.75%
Q2 2021	-	-	-

20 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Immix Biopharma's insiders, as of Q2 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	4	-	-
Q4 2023	2	-	-
Q3 2023	11	-	-
Q4 2022	4	-	-
Q3 2022	-	2	-
Q4 2021	6	-	-
Q2 2021	-	-	-

As of Q2 2024, Insider owners conducted 4 open market buy trades and 0 open market sell trades of Immix Biopharma's stocks.

Immix Biopharma Peer Ownership

Ticker	Company
ZVSA	ZyVersa Therapeutics, Inc.
CNSP	CNS Pharmaceuticals, Inc.
CWBR	CohBar, Inc.
AVRO	AVROBIO, Inc.
EFTR	eFFECTOR Therapeutics, Inc.
OCEA	Ocean Biomedical, Inc.
SONN	Sonnet BioTherapeutics Holdings, Inc.
HEPA	Hepion Pharmaceuticals, Inc.
ELEV	Elevation Oncology, Inc.
ENVB	Enveric Biosciences, Inc.

IMMX Ownership FAQ

Who Owns Immix Biopharma?

Immix Biopharma is owned by institutional shareholders (7.85%), insiders (40.18%), and public (51.97%). The largest institutional shareholder of Immix Biopharma is AIGH CAPITAL MANAGEMENT LLC (6.00% of total shares) and the top mutual fund owner is 360 Funds (0.14% of total shares).

Who are the major institutional shareholders of Immix Biopharma?

Immix Biopharma's major institutional shareholders are AIGH CAPITAL MANAGEMENT LLC, BLEICHROEDER LP, CABLE CAR CAPITAL LLC, VANGUARD GROUP INC, and RENAISSANCE TECHNOLOGIES LLC. The top five shareholders own together 16.24% of the company's share outstanding.

How many Immix Biopharma shareholders are there?

As of Jun 2024, there are 9 institutional shareholders of Immix Biopharma.

What percentage of Immix Biopharma is owned by AIGH CAPITAL MANAGEMENT LLC?

AIGH CAPITAL MANAGEMENT LLC owns 1.41M shares of Immix Biopharma, representing 6.00% of the company's total shares outstanding, valued at $2.79M (as of Jun 2024).

What percentage of Immix Biopharma is owned by BLEICHROEDER LP?

As of Jun 2024, BLEICHROEDER LP holds 850K shares of Immix Biopharma (IMMX), compromising 3.63% of the company, valued at $1.68M.

What percentage of Immix Biopharma is owned by CABLE CAR CAPITAL LLC?

CABLE CAR CAPITAL LLC is the third largest holder of Immix Biopharma. The company owns 796.1K of the company's shares outstanding (worth $1.58M).